Recent Study Highlights the Potential of Medical Cannabis: New Research Report Illuminates the Global Pharmaceutical Landscape
October 30, 2023 06:48 ET
|
Research and Markets
Dublin, Oct. 30, 2023 (GLOBE NEWSWIRE) -- In light of a pivotal study identifying 65 potential cannabis-responsive biomarkers and the recent recommendation by the US Department of Health and Human...
Global Pharmaceutical Cannabis Market Research Report 2021: Epidiolex, Sativex, dronabinol to be Worth Just Under 900 Million Euro as of 2021, Growing to 1.8 Billion Euro by 2025
December 07, 2021 08:13 ET
|
Research and Markets
Dublin, Dec. 07, 2021 (GLOBE NEWSWIRE) -- The "The Pharmaceutical Cannabis Report: 2nd Edition" report has been added to ResearchAndMarkets.com's offering. The author estimates the market size...
Global Pain Therapeutics Markets, Drugs, and Competitive Landscape Report 2021 Featuring Profiles of 173 Companies & their 156 Collaborations - Forecast to 2030
November 23, 2021 06:58 ET
|
Research and Markets
Dublin, Nov. 23, 2021 (GLOBE NEWSWIRE) -- The "Pain Therapeutics - Drugs, Markets and Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering. This report...
Global Medical Marijuana Cannabidiol Pipeline Report 2021 Featuring Bionorica SE, Corbus Pharmaceuticals, Therapix Biosciences, TO Pharmaceuticals, Canbex Therapeutics & InMed Pharma
October 25, 2021 05:33 ET
|
Research and Markets
Dublin, Oct. 25, 2021 (GLOBE NEWSWIRE) -- The "Medical Marijuana - Cannabidiol - Pipeline Insight, 2021" drug pipelines has been added to ResearchAndMarkets.com's offering. "Medical Marijuana -...
2021 Insights on the Pain Therapeutics Global Markets - Advances in Pharmacogenomics and Pharmacogenetics are Enabling the Development of Personalized Approaches to Pain Management
April 16, 2021 08:23 ET
|
Research and Markets
Dublin, April 16, 2021 (GLOBE NEWSWIRE) -- The "Pain Therapeutics - Drugs, Markets and Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering. This report...
Top Three Strategic Imperatives on Cannabinoids Technology, 2020 Report
February 08, 2021 05:38 ET
|
Research and Markets
Dublin, Feb. 08, 2021 (GLOBE NEWSWIRE) -- The "Technology Developments Fuelling Growth Opportunities for Cannabinoids" report has been added to ResearchAndMarkets.com's offering. Cannabinoids as...
Global Pain Therapeutics Markets, 2019-2020 & Forecast to 2029 with Profiles of 173 Companies & 156 Collaborations
October 30, 2020 03:43 ET
|
Research and Markets
Dublin, Oct. 30, 2020 (GLOBE NEWSWIRE) -- The "Pain Therapeutics - Drugs, Markets and Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering. The worldwide...
Oliveda International Inc. (OLVI) Founder Thomas Lommel Successfully Connects World's First Cannabis Plant to the Internet to Provide CBD and Cannabis Frequencies Worldwide for Free
August 06, 2019 08:30 ET
|
OLIVEDA International, Inc.
SANTA MONICA, CA, Aug. 06, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Oliveda International, Inc. (OTC Pink: OLVI), a leading international innovator in natural cosmetics and wearable beauty and...
CURE Pharmaceutical Secures Patent on Oral Thin Film Containing Bioactive Cannabinoid Molecules
May 22, 2019 07:25 ET
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., May 22, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC:CURR), an innovative drug delivery and development company, today announced the issuance of U.S. Patent No. 10,307,397,...
CURE Pharmaceutical Secures U.S. DEA Approval to Manufacture Cannabinoid-based Pharmaceuticals
November 26, 2018 07:25 ET
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif., Nov. 26, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced it has secured a new registration with the...